Reportlinker.com announces that a new market research report is available in its catalogue.
Drug Delivery Markets: Implantable / Injectable and Needle-Free Delivery Systems
http://www.reportlinker.com/p0148033/Drug-Delivery-Markets-Implantable-/-Injectable-and-Needle-Free-Delivery-Systems.html
With pharmaceutical companies increasingly looking for ways to extend the revenue-earning lifetime of their biggest products, drug delivery has become an important focus of the industry. Kalorama's Drug Delivery Markets: Implantable / Injectable and Needle-Free Delivery Systems provides detail for business planners on the market for implantable / injectable delivery system markets.
Biopharmaceutical products are driving growth of needle-free systems; there will likely be significant increases in revenues in the vaccine arena. This report looks at that trend and reports current and forecasted revenues for the implantable/injectable drug delivery market, segmented into two main categories:
- Needle-free drug delivery
- Other Injectable/Implantable
Kalorama's unique analysis offers segmentation of this market for:
- Drug Delivery Technology Revenues
- Pharmaceuticals Sold via Delivery Technology
This breakout makes the report relevant to business plans of either device technology companies or pharmaceutical concerns. (This market analysis does not include drug-eluding stents or prefilled or regular syringes. Kalorama considers these separate markets)
With pharmaceutical companies increasingly turning to drug delivery to extend the revenue-earning lifetime of their biggest products, drug delivery has become an important focus of the pharmaceutical industry.